Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-099002
Filing Date
2023-09-07
Accepted
2023-09-07 17:26:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2323568d4_sc13da.htm SC 13D/A 47490
  Complete submission text file 0001104659-23-099002.txt   49052
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42217 | Film No.: 231243145
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Filed by) CIK: 0001448698 (see all company filings)

Type: SC 13D/A